The Transplantation Society’s Governing Board bestows Honours and Awards to recognize individuals contributing to the field of transplantation through outstanding achievement (for basic scientists, clinicians and in developing countries), and mentorship and training. All members of TTS in good standing are eligible to make nominations and to be nominated for these Awards.
To recognise women role models in the field, The Women in Transplantation Steering Committee has created the following awards:
Professor Sam Shemie, MD
Division of Critical Care Medicine,
Montreal Children's Hospital,
McGill University Health Centre & Research Institute
Professor of Pediatrics, McGill University
Honourary Staff Physician, Department of Critical Care Medicine,
Hospital for Sick Children, University of Toronto
Medical Advisor, Deceased Organ Donation, Canadian Blood Services
We want you to contribute to the Congress by finding a gap in the congress program and submitting your own proposal to fill it. Submissions will be reviewed by the Program Committee and the top proposals will be voted on by the community. Winners will be part of the official program and be hosted in the TTS Innovation Studio in the Exhibit Hall.
TTS and partnering affiliated societies are offering many awards for TTS 2018. All awards require abstract submission, please visit our website for more details.
TTS is seeking nominations for three Officer positions that will be vacated in 2018: President-Elect, Vice President and Treasurer. In addition, five of the 12 Councilors-at-large will be changing.
The Medawar Prize, named after Society co-founder Sir Peter Medawar, is recognized as the world's highest dedicated award for the most outstanding contributions in the field of transplantation.
November 21 - A discarded diabetes drug could be the key to beating organ transplant rejection, a landmark study has found. One in six heart recipients die within a year, and those that do survive face higher risk of infection, weight gain, cancer and diabetes from their life-long regime of immunosuppressant drugs. However, a new study by Queen Mary University of London found that by repurposing a drug designed to treat diabetes, they could speed up the process necessary for the blood system to fuse into the new organ.
November 22 - Scientists have created a new robotic device that can keep a failing heart beating by gently squeezing half of it. The device has only been tested in pigs for now, but it holds the potential to one day save the lives of people with heart failure.
November 22 - Biliary atresia is the most common cause of liver transplants for children in the United States. Now researchers report in Science Translational Medicine finding a strong biomarker candidate that could be used for earlier diagnosis and lifesaving treatments, possibly avoiding more invasive procedures like liver transplant.
November 22 - An uncommon fungal infection appears to have lingered in one man's body for 30 years before making itself known in his brain — and a heart transplant may have played a role in making him sick, a new report of the man's case reveals.
November 14 - With a limited number of lungs available, deciding who gets a transplant can be a matter of life or death. New research from the University of Maryland School of Medicine (UMSOM) suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant and therefore, may mislead clinicians.
November 15 - Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to cure a disease. The experiment was done Monday in California on 44-year-old Brian Madeux. Through an IV, he received billions of copies of a corrective gene and a genetic tool to cut his DNA in a precise spot